Home > Financial Ratios > VALIANT LABORATORIES

VALIANT LABORATORIES
Core EBITDA Growth

    Back to All Ratios
VALIANT LABORATORIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for VALIANT LABORATORIES
Please provide your vote to see the results

VALIANT LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023
   Core EBITDA Growth(%) -96.81-

What is the latest Core EBITDA Growth ratio of VALIANT LABORATORIES ?

The latest Core EBITDA Growth ratio of VALIANT LABORATORIES is -96.81 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024-96.81
Mar2023-

How is Core EBITDA Growth of VALIANT LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2024 -96.81
0
Mar2023 0 -

Other Financial Ratios of VALIANT LABORATORIES


Compare Core EBITDA Growth ratio of peers of VALIANT LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VALIANT LABORATORIES ₹479.2 Cr -1% -12.3% -24.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹393,383.0 Cr 1.8% -3.6% -7.1% Stock Analytics
DIVIS LABORATORIES ₹162,026.0 Cr -2.8% -12.1% 24% Stock Analytics
CIPLA ₹126,159.0 Cr 2.3% 2.4% -4.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,450.0 Cr 2.9% 6.5% 8.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,536.0 Cr 2% -2.4% -13.1% Stock Analytics


VALIANT LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VALIANT LABORATORIES

-1%

-12.3%

-24.7%

SENSEX

-0%

-2.1%

1.1%


You may also like the below Video Courses